Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04095559
Other study ID # 2019-01196; me19Kuehne2
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 5, 2019
Est. completion date May 31, 2021

Study information

Verified date November 2021
Source University Hospital, Basel, Switzerland
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study is to investigate the correlation and to obtain the coefficient of correlation between the global and local bipolar signals (voltage maps) of the LA in sinus rhythm using a focal 4.5 mm irrigated-tip ablation catheter (in combination with microelectrodes), a ring-electrode circular mapping catheter and a microelectrode multipolar catheter in combination with the Rhythmia system.


Description:

Current hypothesis of the mechanism of atrial fibrillation (AF) is a combination of local firing mainly triggered from the pulmonary veins and atrial substrate due to atrial remodelling sustaining AF. Whereas for paroxysmal AF, pulmonary vein isolation (PVI) is still the mainstay of interventional treatment, a left atrial (LA) substrate-based ablation especially in patients with persistent or long-standing persistent AF may be reasonable to improve freedom from AF. In addition, even in patients with paroxysmal AF, substrate-based ablation strategies have been shown to improve outcome. Substrate characterization of the LA is currently performed using the focal ablation catheter with a 3.5mm irrigated tip catheter with a 2 mm interelectrode spacing, a circular (Lasso) or spider like diagnostic (Pentaray) catheter with 1 mm size of the ring electrodes and 2 mm to 4 mm interelectrode spacing. Consequently, the cut-off values to delineate healthy tissue from diseased substrate are defined based on these measures. Since the electrode size and distance between the electrodes determines the bipolar voltage amplitude and morphology (beside their orientation with regard to the propagation wavefront), differences in bipolar voltage values must be expected between different catheter types and especially for the novel micro-electrode catheters IntellaMap Orion and IntellaNav MIFI OI. With the knowledge of the relationship between the bipolar voltage maps created with the different catheter types, information/knowledge from one study obtained with a specific catheter can be transferred to patients treated with the other catheter types. This study is to investigate the correlation and to obtain the coefficient of correlation between the global and local bipolar signals (voltage maps) of the LA in sinus rhythm using a focal 4.5 mm irrigated-tip ablation catheter (in combination with microelectrodes), a ring-electrode circular mapping catheter and a microelectrode multipolar catheter in combination with the Rhythmia system.


Recruitment information / eligibility

Status Completed
Enrollment 25
Est. completion date May 31, 2021
Est. primary completion date May 31, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Documented atrial fibrillation - First or repeat catheter ablation Exclusion Criteria: - Previous heart surgery (high probability for atypical atrial tachycardia and non PV triggers for AF) - Congenital heart disease (corrected or uncorrected) - Severe uncorrected valvular heart disease - Not willing or qualified for Magnetic Resonance Imaging of the heart - Unable to provide informed consent - Pregnancy (Pregnancy test will be performed before study participation) - Patients with pacemaker or intracardiac defibrillator implanted

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
multipolar mapping catheter
mapping of the left atrium will be performed in sinus rhythm using the IntellaMap Orion multipolar mapping catheter (Boston Scientific).
multielectrode circular catheter
mapping of the left atrium will be performed using the multielectrode circular catheter (Lasso, spacing 2-6-2 mm, Biosense Webster)
irrigated ablation catheter
mapping of the left atrium will be performed using the irrigated ablation catheter (IntellaNav Mifi OI)

Locations

Country Name City State
Switzerland Cardiology/Electrophysiology, University Hospital Basel Basel

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Basel, Switzerland Boston Scientific Corporation

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Global bipolar and unipolar signal measured in millivolt (mV) Global bipolar and unipolar signal for the different types of catheters measured in mV single time point assessment at baseline
Primary Local bipolar and unipolar signal measured in mV Local bipolar and unipolar signal for the different types of catheters measured in mV single time point assessment at baseline
Secondary Global fibrosis content and distribution from LGE-MRI measured in [%]. Global fibrosis content and distribution from LGE-MRI measured in [%]. single time point assessment at baseline
Secondary Local fibrosis content and distribution from Late-gadolinium enhanced Magnetic Resonance Imaging (LGE-MRI) measured in [%]. Local fibrosis content and distribution from LGE-MRI measured in [%]. single time point assessment at baseline
Secondary Differences of bipolar voltage characteristics between nearfield and farfield signals: amplitude (mV) Differences of bipolar voltage characteristics between nearfield and farfield signals: amplitude (mV) single time point assessment at baseline
Secondary Differences of bipolar voltage characteristics between nearfield and farfield signals: frequency in Hertz (Hz) Differences of bipolar voltage characteristics between nearfield and farfield signals: frequency (Hz) single time point assessment at baseline
Secondary Differences of bipolar voltage characteristics between nearfield and farfield signals: Duration in milliseconds (ms) Differences of bipolar voltage characteristics between nearfield and farfield signals: duration (ms) single time point assessment at baseline
See also
  Status Clinical Trial Phase
Completed NCT02630914 - Medical and Surgical Hybrid Treatment of Atrial Fibrillation. N/A
Completed NCT05410379 - Antral Lesions Characterization of a New Cryoballoon Ablation System in Terms of Local Impedance Drop
Enrolling by invitation NCT05407415 - KardiaMobile ECG Monitoring Effects on Health Care Utilization and Patient Experience With Atrial Fibrillation N/A
Completed NCT04025710 - Master Study of the BIOMONITOR III and Incision and Insertion Tool (FIT OneStep) N/A
Completed NCT01119274 - EUropean Pharmacogenetics of AntiCoagulant Therapy - Phenprocoumon Phase 4
Recruiting NCT03428048 - Cardiovascular Innovation & Research Institute 's NEXUS Registry, the Whole is Greater Than the Parts.
Recruiting NCT04298723 - Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding. N/A
Completed NCT04218266 - Study to Gather Information About the Proper Dosing of the Oral FXIa Inhibitor BAY 2433334 and to Compare the Safety of the Study Drug to Apixaban, a Non-vitamin K Oral Anticoagulant (NOAC) in Patients With Irregular Heartbeat (Atrial Fibrillation) That Can Lead to Heart-related Complications. Phase 2
Active, not recruiting NCT03732794 - AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment N/A
Active, not recruiting NCT04755283 - Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation Phase 2
Recruiting NCT05712200 - Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76) Phase 3
Recruiting NCT05955365 - Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation Phase 4
Recruiting NCT05294445 - From the Emergency Department Directly to Ablation of Atrial Fibrillation Study N/A
Completed NCT02513316 - Clinical Relevance of Microbleeds In Stroke N/A
Completed NCT04809922 - Accuracy of Cardiac Wearables Devices to Detect Atrial Fibrillation